
Incyte Reveals 2024 Fourth-Quarter and Full Year Financial Results, Offers 2025 Financial Outlook, and Announces Key R&D Achievements
Incyte Reports Financial Results for 2024 and Provides 2025 Outlook Wilmington, Delaware-based biopharmaceutical company, Incyte Corporation ($INCY), recently released its financial results for the fourth quarter and full year 2024. In the announcement, the company also provided its financial guidance for 2025 and highlighted some significant R&D milestones for the upcoming year. Financial Performance in…